Home / Diabetes In Control (page 757)

Diabetes In Control

When is good enough, good enough?

When is good enough, good enough? This past month I have been working on a CE/CME for pharmacists and physicians. The focus has been on diabetes control in the long term care and assisted living facilities. I started on this path because of a conversation with a former colleague who …

Read More »

Treatment Algorithm for Dyslipidemia

Treatment Algorithm for Dyslipidemia The International Diabetes Center has created this treatment algorithm to assist health professionals treating dyslipidemia. The algorithm is based on clinical research and expert opinion, diagram treatment options, timelines and recommended steps. It takes into account the patient’s targets and medication use. Treatment Algorithm for Dyslipidemia

Read More »

FDA Clears New Blood Glucose Test Strips

FDA Clears New Blood Glucose Test Strips: The US Food and Drug Administration (FDA) has approved blood glucose test strips (FreeStyle Lite; Abbott Diabetes Care) to help patients better manage their diabetes by minimizing the potential for interference by other sugars. Abbott now joins the other companies that use strips …

Read More »

Record Number of Medicines Currently in Development to Treat Diabetes

Record Number of Medicines Currently in Development to Treat Diabetes: A record 235 new medicines to treat diabetes, one of the fastest-growing diseases in America, are being developed by America’s pharmaceutical research and biotechnology companies, according to a national report. The new medicines currently in the pipeline, some in early …

Read More »

Almonds Improve Glycemic and Lipid Profiles in Type 2’s

Almonds Improve Glycemic and Lipid Profiles in Type 2’s: Almond consumption is associated with ameliorations in obesity, hyperlipidemia, hypertension, and hyperglycemia. The hypothesis of this 12-week randomized crossover clinical trial was that almond consumption would improve glycemic control and decrease the risk for cardiovascular disease in patients with Type 2 …

Read More »